Your browser doesn't support javascript.
loading
Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinoma.
Nasioudis, Dimitrios; Latif, Nawar A; Ko, Emily M; Cory, Lori; Kim, Sarah H; Simpkins, Fiona; Morgan, Mark A; Giuntoli, Robert L.
Afiliação
  • Nasioudis D; Division of Gynecologic Oncology, Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: dimitrios.nasioudis@uphs.upenn.edu.
  • Latif NA; Division of Gynecologic Oncology, Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Ko EM; Division of Gynecologic Oncology, Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Cory L; Division of Gynecologic Oncology, Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Kim SH; Division of Gynecologic Oncology, Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Simpkins F; Division of Gynecologic Oncology, Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Morgan MA; Division of Gynecologic Oncology, Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Giuntoli RL; Division of Gynecologic Oncology, Penn Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Gynecol Oncol ; 169: 41-46, 2023 02.
Article em En | MEDLINE | ID: mdl-36502768
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Idioma: En Ano de publicação: 2023 Tipo de documento: Article